Achilles Therapeutics to present at the BofA Securities 2021 Virtual Healthcare Conference
Achilles Therapeutics (NASDAQ: ACHL), a clinical-stage biopharmaceutical company, announced its CEO Iraj Ali will participate in a fireside chat at the BofA Securities 2021 Virtual Healthcare Conference on May 13, 2021, at 9:30 a.m. ET. This event highlights the company's work in developing precision T cell therapies targeting clonal neoantigens for treating solid tumors, with ongoing trials for non-small cell lung cancer and melanoma. A webcast of the presentation will be available on their website.
- None.
- None.
LONDON, May 05, 2021 (GLOBE NEWSWIRE) -- Achilles Therapeutics plc (NASDAQ: ACHL), a clinical-stage biopharmaceutical company developing precision T cell therapies to treat solid tumors, today announced that Iraj Ali, Chief Executive Officer, will participate in a fireside chat at the BofA Securities 2021 Virtual Healthcare Conference on Thursday, May 13, 2021, at 9:30 a.m. ET / 2:30 p.m. BST.
A live and archived webcast of the presentation will be available in the Events & Presentations section of the Achilles website.
About Achilles Therapeutics
Achilles is a clinical-stage biopharmaceutical company developing precision T cell therapies targeting clonal neoantigens: protein markers unique to the individual that are expressed on the surface of every cancer cell. The Company has two ongoing Phase I/IIa trials, the CHIRON trial in patients with advanced non-small cell lung cancer (NSCLC) and the THETIS trial in patients with recurrent or metastatic melanoma. Achilles uses DNA sequencing data from each patient, together with its proprietary PELEUS™ bioinformatics platform, to identify clonal neoantigens specific to that patient, and then develop precision T cell-based product candidates specifically targeting those clonal neoantigens.
Further information:
Lee M. Stern – VP, IR & External Communications
+1 (332) 373-2634
l.stern@achillestx.com
Consilium Strategic Communications
Mary-Jane Elliott, Sukaina Virji, Melissa Gardiner
+44 (0) 203 709 5000
achillestx@consilium-comms.com
FAQ
When will Achilles Therapeutics participate in the BofA Securities 2021 Virtual Healthcare Conference?
Who is the CEO of Achilles Therapeutics?
What are the ongoing trials conducted by Achilles Therapeutics?
What is the main focus of Achilles Therapeutics?
How can I access the presentation from the BofA Securities conference?
